Stephanie Bruton
Physician Assistant · Staunton, VANPI 1932692993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 981 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 981 payments — averaging $15.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Lundbeck LLC$1K
- plus $5K from 26 others
What the payments were for
- Food & beverage$14,58997%
- Education$3983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 164 | $3,040 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 177 | $1,710 |
| Otsuka America Pharmaceutical, Inc. | 112 | $1,377 |
| Alkermes, Inc. | 84 | $1,276 |
| Teva Pharmaceuticals USA, Inc. | 62 | $1,237 |
| Lundbeck LLC | 89 | $1,152 |
| Neurocrine Biosciences, Inc. | 61 | $1,036 |
| Johnson & Johnson | 40 | $779 |
| Vanda Pharmaceuticals Inc. | 20 | $476 |
| E.r. Squibb & Sons, L.L.C. | 19 | $469 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $391 |
| Corium, LLC | 15 | $323 |
| Axsome Therapeutics, Inc. | 30 | $273 |
| Noven Therapeutics, LLC | 11 | $171 |
| Ironshore Pharmaceuticals Inc. | 8 | $170 |
| Novo Nordisk | 10 | $168 |
| Sunovion Pharmaceuticals Inc. | 15 | $159 |
| Eisai Inc. | 3 | $112 |
| Supernus Pharmaceuticals, Inc. | 7 | $111 |
| Livanova USA, Inc. | 5 | $89 |
| Avanir Pharmaceuticals, Inc. | 3 | $84 |
| Idorsia Pharmaceuticals US Inc | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $49 |
| Bausch Health US, LLC | 2 | $42 |
| Almatica Pharma LLC | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| Indivior Inc. | 2 | $30 |
| Noven Pharmaceuticals, Inc. | 2 | $26 |
| Neuronetics, Inc. | 1 | $25 |
| Bioxcel Therapeutics, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,987 in reported general payments places this provider in the 95th percentile of 3,376 physician assistant providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 39 | $57,013 |
| RexultiBrexpiprazole | 20 | $39,537 |
| CaplytaLumateperone Tosylate | 20 | $35,038 |
| AuvelityDextromethorphan Hbr/Bupropion | 13 | $14,181 |
| QelbreeViloxazine Hcl | 12 | $12,612 |
| Vilazodone Hcl | 68 | $8,151 |
| Paliperidone ErPaliperidone | 22 | $4,807 |
| Aripiprazole | 62 | $3,172 |
| Lurasidone Hcl | 20 | $2,605 |
| Trazodone Hcl | 112 | $2,445 |
| Escitalopram Oxalate | 195 | $2,421 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 36 | $2,316 |
| Bupropion XlBupropion Hcl | 91 | $1,949 |
| Buspirone Hcl | 71 | $1,819 |
| Olanzapine | 50 | $1,628 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $3,040 | $57,01339 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,377 | $39,53720 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,710 | $35,03820 claims |
| Axsome Therapeutics, Inc.Auvelity | $273 | $14,18113 claims |
| Supernus Pharmaceuticals, Inc.Qelbree | $111 | $12,61212 claims |
| Lilly USA, LLCOlanzapine | $31 | $1,62850 claims |
| Almatica Pharma LLCSertraline Hcl | $39 | $52588 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,376 physician assistant providers in Virginia.
Other physician assistant in Staunton
- John CarterStaunton$90K
- Lauren FacklerStaunton$12K
- John DalessandroSalem$160K
- Jalal AlghabraFredericksburg$119K
- Jamie GiovanelliVirginia Beach$118K
- Melissa AlcoxNorfolk$73K
- Lindsay TomReston$71K
- Robert HigginsonRichmond$66K
- Jameka McElroy-BrooklynArlington$65K
- Hillary HartungNorfolk$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.